Somatic BRCA2 bi-allelic loss in the primary prostate cancer was associated to objective response to PARPi in a sporadic CRPC patient

Ann Oncol. 2017 May 1;28(5):1158-1159. doi: 10.1093/annonc/mdx067.

N Romero-Laorden^{1

2}, E Piñeiro-Yañez³, A Gutierrez-Pecharroman^{2

4}, M I Pacheco^{1

2}, E Calvo⁵, F Al-Shahrour³, E Castro^{1

2}, D Olmos^{1

2

6}

¹ Prostate Cancer Unit, Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, Madrid.
² Prostate Cancer Unit, Spanish National Cancer Research Centre.
³ Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid.
⁴ Pathology Department, Hospital Universitario de Móstoles, Mostoles.
⁵ START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, Madrid.
⁶ CNIO-IBIMA Genito-Urinary Cancer Unit, Medical Oncology Department, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain.

No abstract available

Publication types